title: Inhibitors of sterol synthesis. Metabolism of [2,4-3H]5 alpha-cholest-8(14-)-en-3 beta-ol-15-one after intravenous administration to a nonhuman primate.
abstract: The metabolism of 5 alpha-cholest-8(14)-en-3 beta-ol-15-one, a potent inhibitor of cholesterol synthesis with marked hypocholesterolemic activity, has been studied after the intravenous administration of a mixture of [2,4-3H]5 alpha-cholest-8(14)-en-3 beta-ol-15-one and [4-14C] cholesterol to a baboon. The levels of 3H in plasma which was associated with the free 15-ketosterol decreased very rapidly (T1/2 approximately 9 min) after injection of the labeled sterol. By 4 h, the level of the [3H]15-ketosterol in plasma was negligible. The rapid decrease in the levels of the free 15-ketosterol was associated with rapid formation of fatty acid esters of the 15-ketosterol. The maximum level of 3H-labeled 15-ketosteryl esters was observed at 20 min after the injection of the 15-ketosterol. Thereafter, the levels of the 15-ketosteryl esters decreased rapidly with an apparent T1/2 of approximately 3.5-4.0 h. The results also indicated rapid formation of 3H-labeled cholesterol and cholesteryl esters. Substantial formation of [3H]cholesterol was observed at 20 min after the injection of the 15-ketosterol and reached a maximum level in plasma at 2 h. The maximum levels of [3H]cholesteryl esters in plasma were observed much later. These and other findings indicated that the observed slow clearance of total 3H from plasma is a consequence of metabolism of the 15-ketosterol to cholesterol and cholesteryl esters, normal constituents of plasma whose turnover in the whole animal is known to be relatively slow.
authors.affiliation: Department of Biochemistry, Rice University, Houston, Texas 77251.
authors.forename: G J
authors.initials: GJ
authors.lastname: Schroepfer
authors.forename: A
authors.initials: A
authors.lastname: Kisic
authors.forename: A
authors.initials: A
authors.lastname: Izumi
authors.forename: K S
authors.initials: KS
authors.lastname: Wang
authors.forename: K D
authors.initials: KD
authors.lastname: Carey
authors.forename: A J
authors.initials: AJ
authors.lastname: Chu
mesh_terms: D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D002782:Cholestenes / Q000378:metabolism*; D002783:Cholestenones / Q000378:metabolism*; D002784:Cholesterol / Q000096:biosynthesis*; D002788:Cholesterol Esters / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D006207:Half-Life; D008297:Male; D010215:Papio / Q000378:metabolism*; D012016:Reference Values; D013997:Time Factors
chemical_list: D000924:Anticholesteremic Agents; D002782:Cholestenes; D002783:Cholestenones; D002788:Cholesterol Esters; C015073:cholest-8(14)-en-3-ol-15-one; D002784:Cholesterol